HP

HPQ

Market cap $22.8B

The iPhone maker leads the way for the sector in terms of dollars spent on stock buybacks. But other tech companies have reduced their share counts significantly, as well.

Computer and printer maker HP's (HPQ) stock slid Wednesday, a day after the company announced a major cost-cutting plan that includes layoffs.

Major U.S. equities indexes climbed Thursday afternoon ahead of the Thanksgiving holiday amid renewed optimism about a Federal Reserve rate cut next month. The Dow, S&P 500, and Nasdaq all rose close to 1%.

HP posts a Q4 earnings beat and year-over-year revenue growth, driven by strength across its Personal Systems segment despite Printing declines.

"Little bit of the Santa Claus cheer here," Diane King Hall says as the Opening Bell ringer brought the ho-ho-holiday spirit to the NYSE floor. She kicks off an earnings deep dive with Nicole Petallides into three movers this morning: Dell (DELL), HP Inc. (HPQ), and Deere (DE).

Morning Brief anchor Julie Hyman breaks down the latest market moves for November 26, 2025. Wall Street forecasts are looking rather bullish on what's to come in 2026.

HP Inc. is positioned as a value-oriented income and recovery play, despite lagging the S&P 500 and facing industry headwinds. HPQ's PC segment is showing recovery with AI PC growth and market share gains, while the Print business remains a key profit driver despite declining hardware sales. The company maintains strong free cash flow, a rising dividend (now 4.76% yield), and continues aggressive cost-cutting and AI-focused restructuring.

Tom White and Diane King Hall serve up a full plate of tech stock takeaways, starting with the story of the week: Alphabet (GOOGL) vs Nvidia (NVDA). Tom calls the pullback in Nvidia a "headscratcher" as the company releases comments saying their chips are a "generation ahead" of Google's TPUs.

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 50 points on Wednesday.

HP (HPQ) shares dropped 6% after issuing a weak forecast and announcing up to 6,000 job cuts despite beating quarterly earnings estimates. The Trump administration secured a 71% Medicare discount on Ozempic and Wegovy (NVO), expected to save taxpayers $12 billion starting in 2027.